CASE REPORT: EVALUATION OF RENAL FUNCTION IN A PATIENT WITH ACUTE LIVER FAILURE DUE TO LEPTOSPIRA INFECTION
Main Article Content
Abstract
Introduction: Leptospirosis is a zoonotic infection that, upon transmission, activates an immune response which results in multi-organ dysfunction, including renal involvement. However, the accurate assessment of renal function in these patients is complicated when utilizing markers such as plasma creatinine and Cystatin C, as these parameters may be affected by inflammation or hepatic dysfunction. The objective of this study is to evaluate renal function in patients with a history of acute liver failure due to Leptospira infection, with a focus on the impact of inflammatory responses and hepatic dysfunction on renal biomarkers. Methods: Case report and retrospective literature review. Results: A 53-year-old male patient presented for follow-up 3 months after being diagnosed with acute liver failure due to Leptospira infection. The patient was subsequently diagnosed with chronic kidney disease. Plasma Cystatin C levels were elevated, and eGFR-cys was reduced; however, the patient did not exhibit overt clinical signs of renal failure. Plasma creatinine and eGFR-cre were within normal limits. The urinary microalbumin/creatinine ratio was also normal. Liver function tests showed mild elevation in liver enzymes, with total bilirubin and albumin levels remaining within normal ranges. Conclusion: Elevated cystatin C levels in the context of acute hepatitis may not accurately reflect renal impairment but may rather be a consequence of systemic inflammation. Furthermore, hepatic dysfunction may lead to a reduction in creatinine synthesis, resulting in a falsely elevated eGFR-cre. herefore, when encountering cases of acute hepatitis, particularly those caused by Leptospira, clinicians must exercise caution when relying solely on eGFR-cys to conclude renal failure. The integration of multiple indices or the use of a mixed eGFR formula is a crucial step to prevent overtreatment or misdiagnosis.
Article Details
References
2. Jha P, Jha AK, Dayal VM, Jha SK, Kumar A. Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure. Indian Journal of Gastroenterology. 2021;40(6):563-71.
3. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65(4):1416-21.
4. Senavirathna I, Rathish D, Agampodi S. Cytokine response in human leptospirosis with different clinical outcomes: a systematic review. BMC Infectious Diseases. 2020;20(1):268.
5. Bonilla DA, Kreider RB, Stout JR, Forero DA, Kerksick CM, Roberts MD, et al. Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review. Nutrients [Internet]. 2021; 13(4).
6. Cullaro G, Kanduri SR, Velez JCQ. Acute Kidney Injury in Patients with Liver Disease. Clinical Journal of the American Society of Nephrology. 2022;17(11).
7. Singapura P, Ma Tw Fau - Sarmast N, Sarmast N Fau - Gonzalez SA, Gonzalez Sa Fau - Durand F, Durand F Fau - Maiwall R, Maiwall R Fau - Nadim MK, et al. Estimating Glomerular Filtration Rate in Cirrhosis Using Creatinine-Based and Cystatin C-Based Equations: Systematic Review and Meta-Analysis. (1527-6473 (Electronic)).